HEALTHSTORY 578· JULY 10, 2026

Germany moves to more than double drug rebates as U.S. biotech firms retreat into secrecy

The price of selling a branded medicine in Germany may soon rise sharply for drug companies. German lawmakers passed a bill that would increase the mandatory rebate, the fixed discount manufacturers must return to the country's public…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 577Influencer Hero buys Afluencer, adding 17,000-member creator marketplace to its platform NEXT STORY 579 →Clip Strip Corp. corrects its July retailer investment announcement

Keep reading

More from the desk.

28HEALTH

Spruce Biosciences taps Adrian Quartel for chief medical officer role

A chief medical officer is the executive who decides how a drug company designs its clinical trials, interprets the data that comes back, and makes the medical case to regulators. Spruce Biosciences has filled that seat, hiring Adrian…

health1 MIN

39HEALTH

Federal health officials open a 30-day window to reconsider how children's vaccine recommendations are categorized

The federal government has taken a formal step toward reconsidering how children's vaccines are recommended in the United States, though no existing recommendations have changed. That step is a request for information

health2 MIN

53HEALTH

FDA clears Ultragenyx gene therapy in a week of back-to-back regulatory action

A gene therapy has received clearance for use in American patients, one of at least two approvals the Food and Drug Administration processed in a short stretch this week. Gene therapy, in p

health1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk